Table 3.
Linear Mixed Modeling for Predictors of Expansion Rates in Definitely Decreased Autofluorescence Area and Square Root Area
Predictor | Category | Data∗ | Definitely Decreased Autofluorescence Area Expansion Rate (mm2/yr) |
Definitely Decreased Autofluorescence Square Root Area Expansion Rate (mm/yr) |
||||
---|---|---|---|---|---|---|---|---|
Model Estimate ± SE | F(v1, v2)† | P Value | Model Estimate ± SE | F(v1, v2)† | P Value | |||
Gender | Female | 24 (49) | –0.188 ± 0.341 | F(1, 41.5) = 0.304 | 0.584 | –0.042 ± 0.038 | F(1, 43.1) = 1.225 | 0.274 |
Male | 25 (51) | 1.00 (reference)‡ | 1.00 (reference)‡ | |||||
Eye | Left | 49 (50) | 0.046 ± 0.205 | F(1, 47.6) = 0.050 | 0.824 | 0.001 ± 0.016 | F(1, 47.6) = 0.006 | 0.939 |
Right | 49 (50) | 1.00 (reference)‡ | 1.00 (reference)‡ | |||||
Genotype group | A | 14 (28.6) | 0.25 ± 0.67 | F(2, 42.7) = 1.549 | 0.224 | 0.169 ± 0.074 | F(2, 46.2) = 3.298 | 0.046 |
B | 20 (40.8) | 0.757 ± 0.502 | 0.137 ± 0.056 | |||||
C | 15 (30.6) | 1.00 (reference)‡ | 1.00 (reference)‡ | |||||
Age at baseline assessment (yrs) | 41.3 ± 20.2 | 0.004 ± 0.023 | F(1, 47.4) = 0.025 | 0.876 | 0.007 ± 0.003 | F(1, 67.8) = 7.477 | 0.008 | |
Age at symptom onset (yrs) | 26 ± 23.2 | 0.008 ± 0.021 | F(1, 49.6) = 0.129 | 0.721 | –0.004 ± 0.002 | F(1, 63.6) = 2.466 | 0.121 | |
Baseline visual acuity | 39.9 ± 29.9 | –0.012 ± 0.009 | F(1, 77) = 1.807 | 0.183 | –0.0005 ± 0.001 | F(1, 88.3) = 0.293 | 0.590 | |
Baseline DDAF area/SRA§ | 16.4 ± 28.3 | 0.044 ± 0.01 | F(1, 52.4) = 20.516 | < 0.001 | –0.026 ± 0.011 | F(1, 87.1) = 5.640 | 0.020 |
DDAF = definitely decreased autofluorescence; SE = standard error; SRA = square root area.
Presented as no. (%) or mean ± standard deviation for continuous variables.
Observed F statistic with v1 and v2 degrees of freedom.
The reference level in the categorical predictor is defined as 1.00 (reference).
Definitely decreased autofluorescence area was used as the predictor for area expansion rate, whereas DDAF SRA was the predictor for SRA expansion rate.